BGMD — BG Medicine Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$1.52m
- $1.57m
Annual cashflow statement for BG Medicine, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2011 December 31st | 2012 December 31st | 2013 December 31st | 2014 December 31st | 2015 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -17.6 | -23.8 | -15.8 | -8.06 | -5.3 |
| Depreciation | |||||
| Non-Cash Items | 2 | 2.55 | 1.76 | 0.893 | 1.09 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.199 | -0.385 | -1.37 | -1.13 | 0.463 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -15 | -21.3 | -15.3 | -8.17 | -3.67 |
| Capital Expenditures | -0.093 | -0.085 | -0.132 | 0 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0 | 0.1 | 0 | 0.013 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.093 | -0.085 | -0.032 | 0 | 0.013 |
| Financing Cash Flow Items | -1.29 | -0.256 | -0.289 | -0.243 | -0.96 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 36.5 | 10.3 | 10.3 | 4.54 | 1.06 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 21.4 | -11.1 | -5.04 | -3.63 | -2.6 |